Technical Analysis for CCEL - Cryo-Cell International, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Calm After Storm | Range Contraction | -4.80% | |
| Narrow Range Bar | Range Contraction | -4.80% | |
| Upper Bollinger Band Walk | Strength | -4.80% | |
| Inside Day | Range Contraction | -4.80% | |
| Wide Bands | Range Expansion | -4.80% | |
| Overbought Stochastic | Strength | -4.80% |
| Alert | Time |
|---|---|
| 1.5x Volume Pace | about 12 hours ago |
| 60 Minute Opening Range Breakdown | about 12 hours ago |
| Down 5% | about 12 hours ago |
| Down 3% | about 12 hours ago |
| Fell Below Previous Day's Low | about 12 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 10/10/2024
Cryo-Cell International, Inc. Description
Cryo-Cell International, Inc. is the world’s first private cord blood bank. More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their baby’s cord blood and cord tissue stem cells. In addition to its private bank, Cryo-Cell International has a public banking program in partnership with Duke University. Cryo-Cell’s public bank has provided cord blood for more than 600 transplantations and operates cord blood donation sites across the U.S in prominent hospitals such as Cedars–Sinai Hospital in Los Angeles and Baptist Hospital in Miami. Cryo-Cell’s facility is FDA registered, cGMP-/cGTP-compliant and licensed in all states requiring licensure. Besides being AABB accredited as a cord blood facility, Cryo-Cell was also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. Cryo-Cell owns the exclusive rights to PrepaCyte-CB, the industry’s most advanced cord blood processing technology.
Classification
Sector: Healthcare
Industry: Medical Care Facilities
Keywords: Biology Stem Cell FDA Blood Childbirth Cord Blood
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.498 |
| 52 Week Low | 4.19 |
| Average Volume | 19,054 |
| 200-Day Moving Average | 7.09 |
| 50-Day Moving Average | 6.74 |
| 20-Day Moving Average | 7.32 |
| 10-Day Moving Average | 8.27 |
| Average True Range | 0.59 |
| RSI (14) | 67.32 |
| ADX | 41.98 |
| +DI | 36.50 |
| -DI | 12.96 |
| Chandelier Exit (Long, 3 ATRs) | 7.66 |
| Chandelier Exit (Short, 3 ATRs) | 7.52 |
| Upper Bollinger Bands | 9.68 |
| Lower Bollinger Band | 4.97 |
| Percent B (%b) | 0.8 |
| BandWidth | 64.33 |
| MACD Line | 0.71 |
| MACD Signal Line | 0.48 |
| MACD Histogram | 0.2261 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.63 | ||||
| Resistance 3 (R3) | 9.65 | 9.38 | 9.48 | ||
| Resistance 2 (R2) | 9.38 | 9.15 | 9.36 | 9.43 | |
| Resistance 1 (R1) | 9.05 | 9.01 | 8.92 | 9.03 | 9.38 |
| Pivot Point | 8.78 | 8.78 | 8.71 | 8.77 | 8.78 |
| Support 1 (S1) | 8.45 | 8.55 | 8.32 | 8.43 | 8.08 |
| Support 2 (S2) | 8.18 | 8.41 | 8.17 | 8.03 | |
| Support 3 (S3) | 7.85 | 8.18 | 7.98 | ||
| Support 4 (S4) | 7.83 |
